Computational medicine and drug discovery software market

To Enquire About the Report Click Here

IndustryARC

Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast (2014-2020)

By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography

To Enquire About the Report Click Here

Table of Contents 1. Global Computational Medicine and Drug Discovery Software Market Overview 2. Executive Summary 3. Global Computational Medicine and Drug Discovery Software Market Landscape 3.1. Market share Analysis 3.2. Comparative Analysis 3.2.1.

Product Benchmarking

3.2.2.

End-User Profiling

3.2.3.

Patent Analysis

3.2.4.

Top 5 Financial Analysis

4. Global Computational Medicine and Drug Discovery Software - Market Forces

4.1. Market Drivers 4.2. Market Constraints 4.3. Market Challenges 4.4. Attractiveness of the Industry 4.4.1.

Power of Suppliers

4.4.2.

Power of Customers

4.4.3.

Threat of New entrants

4.4.4.

Threat of Substitution

4.4.5.

Degree of Competition

5. Global Computational Medicine and Drug Discovery Software Market – Strategic Analysis 5.1. Value Chain Analysis 5.2. Pricing Analysis 5.3. Opportunity Analysis

To Enquire About the Report Click Here

5.4. Product Life Cycle Analysis 5.5. Suppliers & Distributors 6. Global Computational Medicine and Drug Discovery Software Market – By Tools 6.1. Introduction 6.2. Databases 6.3. Software 6.4. Others 7. Global Computational Medicine and Drug Discovery Software Market – By Application 7.1. Introduction 7.2. Computational Physiological Medicine 7.3. Drug Discovery and Development 7.4. Medical Imaging 7.5. Disease Modelling 7.6. Predictive Analysis of Drug Targets 7.7. Cellular Simulation 7.8. Simulation Software 7.9. Others 8. Global Computational Medicine and Drug Discovery Software Market – By Geography 8.1. Introduction 8.2. North America 8.2.1.

U.S.

8.2.2.

Canada

8.3. Europe 8.3.1.

U.K.

To Enquire About the Report Click Here

8.3.2.

Germany

8.3.3.

Netherlands

8.3.4.

Norway

8.3.5.

Italy

8.3.6.

Others

8.4. APAC 8.4.1.

China

8.4.2.

Japan

8.4.3.

Korea

8.4.4.

Australia

8.4.5.

Others

8.5. RoW 9. Market Entropy 9.1. New Product Launches 9.2. M&As, Collaborations, Partnerships & JVs 10. Investment Opportunities 11. Company Profiles 11.1.

Aurora Fine Chemicals LLC

11.2.

Biognos AB

11.3.

Certara, L.P.

11.4.

Chemical Computing Group Inc.

11.5.

CLC bio

11.6.

Collaborative Drug Discovery, Inc.

11.7.

Compugen Ltd.

To Enquire About the Report Click Here

11.8.

Crown Bioscience Inc.

11.9.

Dassault Systemes, BIOVIA Corp.

11.10. Domainex Ltd 11.11. Entelos, Inc. 11.12. Genedata AG 11.13. Leadscope, Inc. 11.14. Nimbus Therapeutics 11.15. Prosarix Ltd 11.16. Quant Med LLC 11.17. Quantum Pharmaceuticals 11.18. Rhenovia Pharma Limited 11.19. Simulations Plus, Inc. 11.20. Schrรถdinger, LLC 12. Appendix 12.1.

Abbreviations

12.2.

Sources

12.3.

Research Methodology

12.4.

Bibliography

12.5.

Compilation of Expert Insights

12.6.

Disclaimer

To Enquire About the Report Click Here

LIST OF TABLES Table 1 Product Benchmarking for Global Computational Medicine and Drug Discovery Software Market – By Software ($) Table 2 Global Computational Medicine and Drug Discovery Software Market – Pricing Analysis ($) Table 3 Global Computational Medicine and Drug Discovery Software Market Revenue, By Tools, 2014-2020 ($M) Table 4 Global Computational Medicine and Drug Discovery Software Market Revenue, By Databases, By Application, 2014-2020 ($M) Table 5 Global Computational Medicine and Drug Discovery Software Market Revenue, By Databases, By Geography, 2014-2020 ($M) Table 6 Global Computational Medicine and Drug Discovery Software Market Revenue, By Software, By Application, 2014-2020 ($M) Table 7 Global Computational Medicine and Drug Discovery Software Market Revenue, By Software, By Geography, 2014-2020 ($M) Table 8 Global Computational Medicine and Drug Discovery Software Market Revenue, By Other Tools, By Application, 2014-2020 ($M) Table 9 Global Computational Medicine and Drug Discovery Software Market Revenue, By Other Tools, By Geography, 2014-2020 ($M) Table 10 Global Computational Medicine and Drug Discovery Software Market Revenue, By Application, 2014-2020 ($M) Table 11 Global Computational Medicine and Drug Discovery Software Market Revenue in Computational Physiological Medicine, By Tools, 2014-2020 ($M) Table 12 Global Computational Medicine and Drug Discovery Software Market Revenue in Computational Physiological Medicine, By Geography, 2014-2020 ($M) Table 13 Global Computational Medicine and Drug Discovery Software Market Revenue in Drug Discovery and Development, By Tools, 2014-2020 ($M) Table 14 Global Computational Medicine and Drug Discovery Software Market Revenue in Drug Discovery and Development, By Geography, 2014-2020 ($M) Table 15 Global Computational Medicine and Drug Discovery Software Market Revenue in Medical Imaging, By Tools, 2014-2020 ($M)

To Enquire About the Report Click Here

Table 16 Global Computational Medicine and Drug Discovery Software Market Revenue in Medical Imaging, By Geography, 2014-2020 ($M) Table 17 Global Computational Medicine and Drug Discovery Software Market Revenue in Disease Modelling, By Tools, 2014-2020 ($M) Table 18 Global Computational Medicine and Drug Discovery Software Market Revenue in Disease Modelling, By Geography, 2014-2020 ($M) Table 19 Global Computational Medicine and Drug Discovery Software Market Revenue in Predictive Analysis of Drug Targets, By Tools, 2014-2020 ($M) Table 20 Global Computational Medicine and Drug Discovery Software Market Revenue in Predictive Analysis of Drug Targets, By Geography, 2014-2020 ($M) Table 21 Global Computational Medicine and Drug Discovery Software Market Revenue in Cellular Simulation, By Tools, 2014-2020 ($M) Table 22 Global Computational Medicine and Drug Discovery Software Market Revenue in Cellular Simulation, By Geography, 2014-2020 ($M) Table 23 Global Computational Medicine and Drug Discovery Software Market Revenue in Simulation Software, By Tools, 2014-2020 ($M) Table 24 Global Computational Medicine and Drug Discovery Software Market Revenue in Simulation Software, By Geography, 2014-2020 ($M) Table 25 Global Computational Medicine and Drug Discovery Software Market Revenue in Other Applications, By Tools, 2014-2020 ($M) Table 26 Global Computational Medicine and Drug Discovery Software Market Revenue in Other Applications, By Geography, 2014-2020 ($M) Table 27 Global Computational Medicine and Drug Discovery Software Market, By Geography, 2014-2020 ($M) Table 28 North America: Computational Medicine and Drug Discovery Software Market Revenue,

By Country, 2014-2020 ($M) Table 29 North America: Computational Medicine and Drug Discovery Software Market Revenue,

By Tools, 2014-2020 ($M) Table 30 North America: Computational Medicine and Drug Discovery Software Market Revenue,

By Application, 2014-2020 ($M) Table 31 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By Country, 2014-2020 ($M)

To Enquire About the Report Click Here

Table 32 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By Tools, 2014-2020 ($M) Table 33 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By Application, 2014-2020 ($M) Table 34 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By Country, 2014-2020 ($M) Table 35 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By Tools, 2014-2020 ($M) Table 36 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By Application, 2014-2020 ($M) Table 37 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By Country, 2014-2020 ($M) Table 38 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By Tools, 2014-2020 ($M) Table 39 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By Application, 2014-2020 ($M)

To Enquire About the Report Click Here

LIST OF FIGURES Figure1 Global Computational Medicine and Drug Discovery Software Market, By Geography, 2014 - 2020 ($M) Figure2 Segmentation of Global Computational Medicine and Drug Discovery Software Market Figure3 Global Computational Medicine and Drug Discovery Software Market Competitive Share Analysis, 2014(%) Figure4 Global Computational Medicine and Drug Discovery Software Market Share, By Application, 2014 (%) Figure5 Global Computational Medicine and Drug Discovery Software Market Share, By Geography, 2014 (%) Figure6 North America Computational Medicine and Drug Discovery Software Market Share, By Country, 2014 (%) Figure7 Europe Computational Medicine and Drug Discovery Software Market Share, By Country, 2014 (%) Figure8 APAC Computational Medicine and Drug Discovery Software Market Share, By Country, 2014 (%) Figure9 RoW Computational Medicine and Drug Discovery Software Market Share, By Country, 2014 (%) Figure10 Global Computational Medicine and Drug Discovery Software Market Recent Developments, By Year, 2012-2015

To Enquire About the Report Click Here

1. GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY SOFTWARE MARKET OVERVIEW 1.1 REPORT SCOPE The global market for Computational Medicine and Drug Discovery Software has been segmented by the various tools and their applications in life sciences and healthcare. The major applications for global Computational Medicine and Drug Discovery Software market are found in computational physiological medicine, drug discovery and development, disease modeling, body simulation software development, predicting and analyzing specific drug targets and so on. Each of these segmentations has been studied to give a comprehensive analysis of the global computational medicine and drug discovery software market.

The overall market has also been presented from the perspective of different geographic locations into standard geographic regions and key economies for this market. Competitive landscape for each of the capture technologies and storage methods is highlighted and the market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided. The prominent players profiled in this report are Compugen Ltd., Certara, L.P., Dassault Systemes BIOVIA Corp., Schrรถdinger, LLC, Genedata AG and others.

The report contains the most detailed and in-depth segmentation and analysis of the global computational medicine and drug discovery software market during the period 2014 - 2020.

To Enquire About the Report Click Here

1.2 Stakeholders The following are the prominent stakeholders in the global computational medicine and drug discovery software market.  Healthcare professionals  Chemical and Pharmaceutical experts  IT and Software developers  Bio-informatics professionals  Bio-Technologists and Bio-medical engineers  Universities and R&D institutes  Regulatory authorities  Patients

To Enquire About the Report Click Here

2. EXECUTIVE SUMMARY The computational medicine and drug discovery software market encompasses the use of pharmacy, chemistry, biotechnology and software knowledge for drug discovery and development. This is accompanied by development of algorithms and simulation of various models to study the pharmacokinetics and pharmacodynamics of a particular drug.

The global market for computational medicine and drug discovery software is valued at $X billion in 2014 and is projected to grow with a healthy double digit CAGR of XX% through 2020. Recent growth in disease modeling, drug designing and development by leveraging various bioinformatics tools will lead to the market growth during the period under study (2014-2020).

SAMPLE TABLE: GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY SOFTWARE MARKET, BY APPLICATION, 2014-2020 ($M) Application

2014

2015

Computational xx xx Physiological Medicine Drug Discovery and xx xx Development Medical Imaging xx xx Disease Modeling xx xx Predictive Analysis xx xx of Drug Targets Cellular Simulation xx xx Simulation Software xx xx Others xx xx Total xx xx Source: IndustryARC Analysis, Expert Insights

2016

2017

2019

2020

CAGR% (20152020)

xx

xx

xx

xx

xx%

xx

xx

xx

xx

xx%

xx xx xx

xx xx xx

xx xx xx

xx xx xx

xx% xx% xx%

xx xx xx xx

xx xx xx xx

xx xx xx xx

xx xx xx xx

xx% xx% xx% xx%

As of 2014, the application of computational medicine in simulation of cells is estimated to grow at the fastest pace, due to the increasing research activities on sequencing of proteins to design and develop customized medicines suited to an individual’s needs. Drug discovery, development and disease modeling applications occupy the highest market share owing to the widespread drug development approaches adopted by several major pharmaceutical companies.

To Enquire About the Report Click Here

SAMPLE FIGURE: GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY SOFTWARE MARKET, BY REGION, 2014 (%)

North America Europe APAC RoW

Source: IndustryARC Analysis, Expert Insights

The North America, led by the U.S. accounted for the largest market share in the global market for computational medicine and drug discovery software, occupying over 55% of the revenue in 2014.

The huge market size can be credited to the increasing investments in R&D activities pertaining to drug discovery and development and disease modeling.

To Enquire About the Report Click Here

KEY MARKET INSIGHTS  Disease modelling and Drug discovery applications occupied the highest market share in 2014, in terms of applications, accounting for more than 55% of the total market revenue.  APAC region is poised to witness the fastest market growth during the forecast period, with an estimated CAGR exceeding 25% owing to the increased R&D spending on pharmacokinetics and pharmacogenomics studies.  The global market for computational medicine and drug discovery in 2014 is dominated by the databases, when segmented in terms of tools. However, the software tools are estimated to growth with the highest CAGR due to the growing usage in drug designing and modelling.  Certara, L.P., in December, 2014 has launched “Muse Invent” in Japan, which a molecular design workflow that empowers researchers to design drugs with novel structures or scaffolds for individuals requirements.  Schrödinger, Inc. and Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) in September, 2014 have signed agreements to give access to Schrödinger’s Small-Molecule Drug Discovery Suite and two other suites to Tri-I TDI’s researchers in order to proceed in preliminary research towards new therapeutics.

To Enquire About the Report Click Here

12.3 RESEARCH METHODOLOGY The quantitative and qualitative data collected for the global computational medicine and drug discovery market report is from a combination of secondary and primary sources. Research interviews were conducted with executives and/or mangers in the key device, software manufacturers and related organizations. These Key Opinion Leaders (KOLs) were then provided a questionnaire to gather quantitative and qualitative inputs on their operations, performance, strategies and views on the overall market, including key developments and trends. Data from interviews is consolidated, checked for consistency and accuracy, and the final market numbers are again validated by experts. The global computational medicine and drug discovery market was split by the tools, applications and geography based on different factors like primary and secondary sources, understanding of the number of companies operating in each segment and also KOL insights.

We have used various secondary sources such as directories, articles, white papers, newsletters, annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and collect information for extensive commercial study of the global computational medicine and drug discovery market.

The approach towards finding information regarding the market and forecasting has been quite extensive. The key players in the market and its value chain were identified through secondary research and their market opinions were also gathered in a similar way through telephonic interviews and questionnaires. Interviews with key opinion leaders such as managers and marketing personnel were used extensively in understanding the need and emergence of computational medicine and drug discovery market.

We also have extensive database of contacts which were used to conduct primary interviews and also to get their inputs using questionnaires.

To Enquire About the Report Click Here

THE ARC ADVANTAGE An analytical model lies at the core of our process, ensuring logical consistency throughout our research. We complement the model with secondary data and interviews with industry experts to reflect the latest trends. With our final expert validation, we provide you with only the most accurate and actionable intelligence.

THE ARC PROCESS Analytical Method 1. Granular breakdown of drivers into factors 2. Validate all factors in terms of their present impact on the market 3. Assign weights to these factors in terms of their relevance and impact on the market 4. Build the Analytical Model ANALYTICAL MODEL

Base Method

1. Get a topdown estimate of the market 2. Follow it up with a bottom-up estimate of the market 3. Check forconsistency and new growth factors that are relevant over the next 10 Years

4. Build the Base model BASE MODEL

Consolidation Method 1. Granular breakdown of drivers into factors 2. Validate all factors in terms of their present impact on the market.

3. Assign weights to these factors in terms of their relevance and impact on the market.

4. Build the Consolidated Model

Delphi Verification 1. Verify the findings of the model with experts from across the value chain 2. Verify the findings with players across small and large enterprises 3. Tweak the model and add new factors 4. Finalize the ARC Model

CONSOLIDATED MODEL

ARC MODEL

To Enquire About the Report Click Here

ABOUT US IndustryARC was started by a group of young, passionate professionals along with extensively experienced industry veterans across various business segments. Our focus and expertise is mainly in the field of analytics, market research and consulting. Our singular goal is to provide accurate and affordable research to our clients.

Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the expertise maybe, everyone in our team shares one common trait - we love data and we love providing solutions to clients using that data even more! Seeing your business flourish based on our solutions and strategy is what we love the most!

IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries.

Our reports are in-depth and high quality reports that can help decision makers frame better strategies for their business requirements. These reports can be further customized as per your needs.

Disclaimer: •

The reports sold by IndustryARC are limited publications containing valuable market information provided to a select group of customers in response to orders.

•

Our customers acknowledge and agree that any report bought from IndustryARC is for their own internal use and not for general publication or disclosure to third parties.

•

Our reports or part of the reports, information contained in the report, cannot be shared or resold to any other third party.

•

Disclosure to third parties, usage of data in a public document, article or blog by the customer can be done with prior permission taken from IndustryARC.

For information regarding permissions and sales, contact: sales@industryarc.com | sanjay.matthews@industryarc.com

To Enquire About the Report Click Here

IndustryARC +1 614 - 588 - 8538 sales@industryarc.com

Copyright Š2015 IndustryARC All Rights Reserved. This document contains highly confidential information and is the sole property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of IndustryARC.